We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+22.64%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
AUM
$200M
AUM Growth
-$13K
Cap. Flow
-$28.9M
Cap. Flow %
-14.4%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$28.9M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$118M 58.7%
2,621,575
-687,120
-21% -$28.9M
OCUL icon
2
Ocular Therapeutix
OCUL
$2.38B
$60.8M 30.35%
2,585,607
ASXC
3
DELISTED
Asensus Surgical, Inc.
ASXC
$22M 10.96%
580,515

Similar funds

SV Health Investors's Q4 2014 Portfolio in Review

As of Q4 2014, SV Health Investors held 3 positions worth $200M, down 0.01% from $200M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors withdrew a net $28.9M in Q4 2014, reducing 1 holding. Its largest reduction was IVERIC bio, Inc. Common Stock, cutting an estimated $28.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SV Health Investors's biggest Q4 2014 reduction was IVERIC bio, Inc. Common Stock, cutting an estimated $28.9M.
  • SV Health Investors's ten largest holdings make up 100% of its $200M portfolio in Q4 2014.
  • SV Health Investors opened 0 new positions and closed 0 in Q4 2014.
  • SV Health Investors's portfolio value fell 0.01% quarter-over-quarter to $200M.

Based on SV Health Investors's 13F filing for Q4 2014, filed 13 Feb 2015.